7 completed, 6 recruiting, 3 active not recruiting, 2 unknown. 12 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 12 | Completed 4, Active not recruiting 3, Recruiting 3, Unknown 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Human Papillomavirus DNA Tests: new trials by email Literature Review of Human Papillomavirus DNA Tests trials Research Report on Human Papillomavirus DNA Tests
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population Physical examination, Liquid-based cytology, Molecular screening - Atypical Squamous Cell of Undetermined Significance, ASC-US | Not applicable | Withdrawn | Timser SAPI de CV | 2026-02-27 | 2026-03-03 | |
| Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer Physical examination, Liquid-based cytology, Molecular screening - I) Atypical Squamous Cells of Undetermined Significance (ASC-US), II) Atypical Glandular Cells of Uncertain Significance (AGUS) | Not applicable | Recruiting | Timser SAPI de CV | 558 | 2026-02-03 | 2026-03-18 |
| Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04) Biospecimen Collection, Cervical Biopsy, Colposcopy - Cervical Carcinoma, Human Papillomavirus Infection | Not applicable | Recruiting | National Cancer Institute (NCI) | 500 | 2025-11-24 | 2026-07-31 |
| Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer HPV Test, EVA System, Visual Inspection with Acetic Acid (VIA) - Human Papillomavirus (HPV), Cervical Intraepithelial Neoplasia | Not applicable | Recruiting | DL Analytics | 10000 | 2025-02-12 | 2026-01-29 |
| Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02) Biospecimen Collection, Cervical Biopsy, Colposcopy - Cervical Carcinoma, Human Papillomavirus Infection | Not applicable | Active not recruiting | National Cancer Institute (NCI) | 500 | 2024-09-13 | 2026-07-07 |
| Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03) Biospecimen Collection, Cervical Biopsy, Colposcopy - Cervical Carcinoma, Human Papillomavirus Infection | Not applicable | Active not recruiting | National Cancer Institute (NCI) | 500 | 2024-09-11 | 2026-07-07 |
| Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01) Biospecimen Collection, Cervical Biopsy, Colposcopy - Cervical Carcinoma, Human Papillomavirus Infection | Not applicable | Active not recruiting | National Cancer Institute (NCI) | 750 | 2024-06-26 | 2026-09-29 |
| Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology Vaginal specimens for HPV test will be collected by participants themselves using flocked swabs after explanations by co-investigators. - Cervical Cancer Screening, HPV Infections | Completed | University Hospital, Geneva | 500 | 2024-06-01 | 2026-01-21 | |
| Post-operative Monitoring of Gastric Cancer DNA test - Gastric Cancer | Recruiting | Suzhou Huhu Health & Technology Inc. | 258 | 2024-02-18 | 2025-06-18 | |
| Early Detection and Post-operative Monitoring of Gastric Cancer DNA test - Gastric Cancer | Recruiting | Suzhou Huhu Health & Technology Inc. | 1197 | 2024-02-18 | 2025-06-06 | |
| Detecting HPV DNA in Anal and Cervical Cancers Radiation Treatment With or Without Chemotherapy, Blood Sample Collection, HPV Genotyping (HPV DNA Test) - Cervical Cancer, Anal Cancer | Recruiting | University of Chicago | 20 | 2020-10-06 | 2026-03-04 | |
| Papillomavirus Load in Rheumatic Inflammatory Diseases Cervical smear, Pregnancy test, Sexual activity questionnary - Spondyloarthritis, Rhumatoid Arthisis | Not applicable | Unknown | Hospices Civils de Lyon | 385 | 2020-01-09 | 2021-07-27 |
| The Study for the "Cervical Cancer Screening and Treatment Algorithms Study Using HPV Testing in Africa" HPV DNA Test, VIA triage test, Treatment by ablative treatment - HPV Infection | Phase 3 | Unknown | International Agency for Research on Cancer | 1500 | 2019-10-01 | 2024-03-13 |
| Promoting Comprehensive Cervical Cancer Prevention and Better Women Health in Cameroon HPV Test - Cervical Cancer | Not applicable | Completed | Prof. Patrick Petignat | 4473 | 2018-10-01 | 2025-01-15 |
| Algorithm for Cervix Carcinoma Screening in CZ Using the Detection of HPV DNA and CINtec Plus HPV DNA test with selective HPV 16/18 genotyping (cobas® 4800 HPV Test, Roche), p16 and Ki-67 biomarker detection in the form of dual cytological staining (CINtec Plus, Roche), standard conventional cytology PAP test - Algorithm for Cervix Carcinoma Screening | Completed | AeskuLab Pathology Prague | 2426 | 2017-09-01 | 2022-10-13 | |
| The HPV Self-test as a Test of Cure in Madagascar HPV test - Human Papilloma Virus Infection, Cervical Intraepithelial Neoplasia Grade 2/3 | Not applicable | Completed | University Hospital, Geneva | 117 | 2016-06-01 | 2016-10-17 |
| Post Colposcopy Management of ASC-US and LSIL Pap Tests Colposcopy, Pap test, HPV test - Cervical Cancer Screening | Not applicable | Completed | University of Calgary | 133 | 2012-01-01 | 2018-05-02 |
| Optimal Strategy for the Management of ASCUS Cytology in Health Care Services of Medellin, Colombia HPV test, COLPOSCOPY, cytology - Cervical Abnormalities, Cervical Intraepithelial Neoplasia Grade 2/3 | Not applicable | Completed | Universidad de Antioquia | 2661 | 2011-01-01 | 2019-09-19 |
| Intended Use Study of the BD SurePath Plus™ Pap BD SurePath Plus Pap test, BD SurePath Pap test, colposcopy with biopsy/ECC - Uterine Cervical Neoplasms, Uterine Cervical Cancer | Terminated | Becton, Dickinson and Company | 5859 | 2010-09-01 | 2023-05-16 | |
| Neulasta in Type 1 Diabetes Neulasta (Pegylated), Placebo, Mixed Meal Tolerance Test (MMTT) - Type 1 Diabetes | Phase 1 | Completed | University of Florida | 21 | 2008-04-01 | 2015-04-09 |
Uterine Cervical Neoplasms (13) · Papillomavirus Infections (8) · Uterine Cervical Dysplasia (5) · Atypical Squamous Cells of the Cervix (2) · Neoplasms (2) · Stomach Neoplasms (2) · Anus Neoplasms (1) · Diabetes Mellitus, Type 1 (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1)
National Cancer Institute (NCI) (4) · Suzhou Huhu Health & Technology Inc. (2) · Timser SAPI de CV (2) · University Hospital, Geneva (2) · AeskuLab Pathology Prague (1) · Becton, Dickinson and Company (1) · DL Analytics (1) · Hospices Civils de Lyon (1) · International Agency for Research on Cancer (1) · Prof. Patrick Petignat (1) · Universidad de Antioquia (1) · University of Calgary (1) · University of Chicago (1) · University of Florida (1)
United States (7) · China (2) · Mexico (2) · Puerto Rico (2) · Cameroon (1) · Colombia (1) · Czechia (1) · El Salvador (1) · France (1) · Madagascar (1) · Senegal (1) · South Africa (1) · Switzerland (1)
Vikrant V Sahasrabuddhe (4) · Leopoldo E Gatica-Galina, MD in OB/GY & Gynecol Oncol (2) · Alejandra Botero, MSc (1) · Armando Baena, MSc, PhD (1) · Astrid Bedoya, MSc (1) · Calatina Villa, BSc (1) · Carlos A Buitrago, MD, Esp (1) · Christina Son, MD (1) · David Levitz, PhD (1) · Dazhi Xu, MD., PhD, (1) · Gloria I Sanchez, MSc, PhD (1) · Gregg Nelson, MD, FRCSC, PhD (1) · Guadalupe Posada, MD, Esp (1) · Juan C Ochoa, MD, Esp (1)
PMID 32049551, PMID 32617889, PMID 33711896, PMID 35109806, PMID 35379615, PMID 36549727, PMID 37751376, PMID 41420163
2016 (1), 2017 (1), R21DK078863 (1), R44CA247137 (1)